Ph2 Modafinil Meth - 1
Status: | Completed |
---|---|
Conditions: | Psychiatric |
Therapuetic Areas: | Psychiatry / Psychology |
Healthy: | No |
Age Range: | 18 - 65 |
Updated: | 8/11/2016 |
Start Date: | December 2007 |
End Date: | March 2010 |
Phase2, Double-blind, Placebo-controlled Trial of Modafinil for the Treatment of Methamphetamine Dependence
The purpose of this study will be to examine the safety and efficacy of modafinil in
increasing number of methamphetamine non-use weeks in subjects with methamphetamine
dependence.
increasing number of methamphetamine non-use weeks in subjects with methamphetamine
dependence.
Inclusion Criteria:
- Must be between the ages of 18 and 65
- Methamphetamine dependent as defined by DSM-IV criteria
- Must be in good general heath with a history of methamphetamine use at screening
- Must be able to provide written informed consent
- If female and of child bearing potential, must agree to use birth control.
Exclusion Criteria:
- Please contact site for more information
We found this trial at
8
sites
Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials
